Dr. Gieschen on the Side Effects of Radiation Therapy in NSCLC

Video

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses the safety profile of radiation therapy in patients with non–small cell lung cancers (NSCLC).

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses the safety profile of radiation therapy in patients with non—small cell lung cancer (NSCLC).

Side effects of radiation may include skin reactions and some irritation of the lung. Physicians will usually differentiate between acute side effects that may occur when the patient is undergoing treatment and long-term side effects that may manifest months or years after the treatment.

The acute side effects are usually transient and are not cause for concern. Long-term side effects can result in lung fibrosis and diminished lung volume and capacity. As in surgery, the concern is a patient’s insufficient lung capacity after treatment.

One of the most significant side effects that can result from radiation therapy is radiation pneumonitis, which is not due to bacteria or infection, but the radiation itself. Some of these patients require steroid treatments which can be difficult to handle.

Related Videos
Daniel Hart, PhD, on CRISPR-Mediated, In Vivo Epigenomic Activation
Luke Roberts, MBBS, PhD, on Developing Gene Therapy for Congestive Heart Failure
PJ Brooks, PhD, on Improved Newborn Screening, Non-Viral Gene Editing: New Frontiers for Neuromuscular Disease
Sowmya Viswanathan, PhD, on Translating Cell Therapies to the Clinic at ISCT 2024
Omar Nadeem, MD, on Initial Efficacy of GPRC5D-CAR in R/R Multiple Myeloma
Omer A. Abdul Hamid, MD, on Improving Gene Therapy’s Effect and Accessibility
George Tachas, PhD, on Tackling DMD Treatment From Multiple Angles
David Suhy, PhD, the cofounder and chief scientific officer of Earli
Deepak L. Bhatt, MD, MPH, MBA, on Incorporating AI into Genetic Research for Cardiovascular Disease
Jeffrey Chamberlain, PhD, on Helping Progress Cell and Gene Therapy Development
© 2024 MJH Life Sciences

All rights reserved.